Liquidia Corp
LQDA
96 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Apr 15 8:43 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 24,733 | $38.71 | $957.4K | — | View → |
| Apr 15, 2026 | Apr 15 8:42 PM | MICHAEL KASETA | Proposed Sale | 139,390 | $38.71 | $5.4M | — | View → |
| Apr 13, 2026 | Apr 14 9:08 PM | Scott MoomawChief Commercial Officer | Sale | 10,547 | $38.34 | $404.4K | 184,558(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Jason AdairChief Business Officer | Sale | 7,301 | $38.37 | $280.1K | 215,426(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Dana BoyleChief Accounting Officer | Sale | 5,101 | $38.37 | $195.7K | 176,918(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Michael KasetaCFO and COO | Sale | 18,958 | $38.37 | $727.4K | 405,775(D) | View → |
| Apr 10, 2026 | Apr 14 9:07 PM | Michael KasetaCFO and COO | Sale | 23,821 | $40.14 | $956.2K | 411,855(D) | View → |
| Apr 13, 2026 | Apr 14 9:06 PM | Sarah KreppChief Human Resource Officer | Sale | 4,557 | $38.37 | $174.9K | 147,019(D) | View → |
| Apr 13, 2026 | Apr 14 9:06 PM | Rajeev SaggarChief Medical Officer | Sale | 9,220 | $38.37 | $353.8K | 173,270(D) | View → |
| Apr 13, 2026 | Apr 14 9:05 PM | Russell SchundlerGeneral Counsel | Sale | 13,692 | $38.37 | $525.4K | 610,532(D) | View → |
| Apr 13, 2026 | Apr 14 9:05 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 32,744 | $38.37 | $1.3M | 1,137,599(D) | View → |
| Apr 10, 2026 | Apr 14 9:05 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 21,433 | $40.12 | $859.9K | 1,495,234(I) | View → |
| Apr 14, 2026 | Apr 14 8:37 PM | MICHAEL KASETA | Proposed Sale | 3,000 | $38.85 | $116.5K | — | View → |
| Apr 9, 2026 | Apr 13 9:47 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.12 | $1.0M | 1,516,667(I) | View → |
| Apr 9, 2026 | Apr 13 9:47 PM | Michael KasetaCFO and COO | Sale | 133,789 | $40.24 | $5.4M | 411,855(D) | View → |
| Apr 10, 2026 | Apr 10 8:35 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $40.32 | $1.0M | — | View → |
| Apr 10, 2026 | Apr 10 8:34 PM | MICHAEL KASETA | Proposed Sale | 23,821 | $40.32 | $960.5K | — | View → |
| Apr 9, 2026 | Apr 9 8:22 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $38.19 | $954.8K | — | View → |
| Apr 9, 2026 | Apr 9 8:21 PM | MICHAEL KASETA | Proposed Sale | 133,789 | $38.19 | $5.1M | — | View → |
| Mar 27, 2026 | Mar 30 9:43 PM | Stephen M BlochDirector | Sale | 62,550 | $35.94 | $2.2M | 2,188,935(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Oct 14 12:05 AM | Russell SchundlerGeneral Counsel | Option Exercise | 10,167 | — | 57,680(D) | View → |
| Oct 9, 2026 | Oct 14 12:04 AM | Rajeev SaggarChief Medical Officer | Option Exercise | 8,016 | — | 40,376(D) | View → |
| Oct 9, 2026 | Oct 14 12:03 AM | Scott MoomawChief Commercial Officer | Option Exercise | 7,466 | — | 39,222(D) | View → |
| Oct 9, 2026 | Oct 14 12:02 AM | Sarah KreppChief Human Resource Officer | Option Exercise | 3,178 | — | 28,609(D) | View → |
| Oct 9, 2026 | Oct 14 12:00 AM | Michael KasetaCFO and COO | Option Exercise | 12,877 | — | 63,448(D) | View → |
| Oct 9, 2026 | Oct 13 11:59 PM | Roger JeffsDirector, Chief Executive Officer | Option Exercise | 28,166 | — | 128,996(D) | View → |
| Oct 9, 2026 | Oct 13 11:59 PM | Dana BoyleChief Accounting Officer | Option Exercise | 3,178 | — | 28,609(D) | View → |
| Oct 9, 2026 | Oct 13 11:58 PM | Jason AdairChief Business Officer | Option Exercise | 10,248 | — | 34,816(D) | View → |
| Sep 14, 2026 | Sep 15 8:30 PM | Raman SinghDirector | Option Exercise | 8,468 | $9.31 | 0(D) | View → |
| Sep 11, 2026 | Sep 15 8:30 PM | Raman SinghDirector | Option Exercise | 9,024 | $9.31 | 8,468(D) | View → |
| Aug 21, 2026 | Aug 25 8:30 PM | Jason AdairChief Business Officer | Option Exercise | 31,799 | $14.20 | 0(D) | View → |
| Aug 20, 2026 | Aug 21 8:30 PM | Katherine Rielly-GauvinDirector | Option Exercise | 18,393 | $2.59 | 0(D) | View → |
| Aug 19, 2026 | Aug 21 8:30 PM | Katherine Rielly-GauvinDirector | Option Exercise | 36,789 | $2.59 | 6,666(D) | View → |
| Aug 19, 2026 | Aug 19 10:21 PM | Rajeev SaggarChief Medical Officer | Option Exercise | 50,000 | $3.73 | 150,000(D) | View → |
| Jul 10, 2026 | Jul 15 12:11 AM | Sarah KreppChief Human Resource Officer | Option Exercise | 3,179 | — | 31,787(D) | View → |
| Jul 10, 2026 | Jul 15 12:08 AM | Michael KasetaCFO and COO | Option Exercise | 12,879 | — | 70,497(D) | View → |
| Jul 10, 2026 | Jul 15 12:07 AM | Roger JeffsDirector, Chief Executive Officer | Option Exercise | 28,167 | — | 143,329(D) | View → |
| Jul 10, 2026 | Jul 15 12:05 AM | Jason AdairChief Business Officer | Option Exercise | 10,251 | — | 38,684(D) | View → |
| Jul 10, 2026 | Jul 15 12:04 AM | Russell SchundlerGeneral Counsel | Option Exercise | 10,168 | — | 64,089(D) | View → |
| Jul 10, 2026 | Jul 15 12:02 AM | Rajeev SaggarChief Medical Officer | Option Exercise | 8,018 | — | 44,862(D) | View → |
Page 1 of 3
Next →